<SEC-DOCUMENT>0000950142-16-003743-index.html : 20160517 <SEC-HEADER>0000950142-16-003743.hdr.sgml : 20160517 <ACCEPTANCE-DATETIME>20160517164456 ACCESSION NUMBER: 0000950142-16-003743 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20160517 DATE AS OF CHANGE: 20160517 GROUP MEMBERS: AISLING CAPITAL II, LP GROUP MEMBERS: AISLING CAPITAL PARTNERS, LLC GROUP MEMBERS: AISLING CAPITAL PARTNERS, LP GROUP MEMBERS: ANDREW SCHIFF GROUP MEMBERS: DENNIS PURCELL GROUP MEMBERS: SEACHAID PHARMACEUTICALS LLC GROUP MEMBERS: STEVE ELMS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88806 FILM NUMBER: 161658050 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Aisling Capital II LP CENTRAL INDEX KEY: 0001350778 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 88 SEVENTH AVE 30TH FL CITY: NEW YORK STATE: NY ZIP: 10106 MAIL ADDRESS: STREET 1: 88 SEVENTH AVE 30TH FL CITY: NEW YORK STATE: NY ZIP: 10106 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>eh1600617_13g-cidara.htm <DESCRIPTION>SCHEDULE 13G <TEXT> Document 1 - file: eh1600617_13g-cidara.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>eh1600617_ex9901.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: eh1600617_ex9901.htm
</DOCUMENT> </SEC-DOCUMENT>